Leukogene Therapeutics Inc.

Mount Pleasant, SC

UEI
DDD1BU62TM94
CAGE
6T1N7
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Veteran Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
4120 Whiting St, Mt Pleasant, SC 29466, USA
Website
leukogene.com
Founded
2012
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
AGR2-superantigen vaccine conjugate for the treatment of pancreaticductal adenocarcinoma R44CA268138 National Cancer Institute (NIH) $3,117,360
AGR2-superantigen vaccine conjugate for the treatment of pancreaticductal adenocarcinoma R42CA268138 National Cancer Institute (NIH) $1,246,043
Bispecific t cell engagers for the treatment of pancreatic ductal adenocarcinoma - ---project summary/abstract… R41CA265624 National Cancer Institute (NIH) $1,085,893
Proteasome inhibitor RE-sensitizing molecules for treatment of refractory multiple myeloma R41CA213488 National Institutes of Health $219,605
Proteasome inhibitor RE-sensitizing molecules for treatment of refractory multiple myeloma R42CA213488 National Cancer Institute (NIH) $1,764,695

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

Vendor Location Primary NAICS
Oncotab, Inc. UEI E5FXNY7GG5M5 Waxhaw, NC 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Senex Biotechnology Inc. UEI G8XKMW3DYMQ6 Maynard, MA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Marker Therapeutics Inc. UEI CK3KR85CSP23 Houston, TX 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PDX Pharmaceuticals Inc. UEI VTX7JRKLC3F5 Portland, OR 541713 Research and Development in Nanotechnology
Glytr Therapeutics, Inc. UEI ZKQLT6S8LXY9 Irvine, CA —

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Leukogene Therapeutics Inc. is a for-profit, corporate entity registered to receive federal grants and contracts. It is structured as a Subchapter S corporation focused on developing innovative therapies for cancer treatment. Based on the award information, Leukogene Therapeutics appears to specialize in cancer immunotherapy research and drug development.

Leukogene Therapeutics has received multiple federal grant awards from the National Cancer Institute (NCI) within the National Institutes of Health (NIH) to support its research efforts. The awards aim to develop novel cancer vaccines and immunotherapies targeting pancreatic ductal adenocarcinoma (PDAC), a deadly form of pancreatic cancer. One project involves an AGR2-superantigen vaccine conjugate intended to stimulate an anti-PDAC immune response. Another focuses on creating bispecific T-cell engagers that bind to AGR2 and CD3 to activate T-cell killing of PDAC cells. The grants fund preclinical research, including in vivo efficacy studies, biomarker analysis, synergy evaluation with checkpoint inhibitors, and optimization of drug candidates. The funding amounts range from approximately $1 million to $1.6 million, with project periods spanning 2-4 years. These awards demonstrate Leukogene Therapeutics' expertise in cancer immunology, vaccine development, and targeted immunotherapies for addressing unmet medical needs in pancreatic cancer treatment.

Quick answers

Is Leukogene Therapeutics Inc. registered in SAM.gov?

Yes. Leukogene Therapeutics Inc.'s SAM.gov registration is active through July 1, 2027.

What is Leukogene Therapeutics Inc.'s most recent federal award?

Leukogene Therapeutics Inc.'s most recent federal grant award is AGR2-superantigen vaccine conjugate for the treatment of pancreaticductal adenocarcinoma (R44CA268138), from National Cancer Institute (NIH), on May 17, 2022.

On GovTribe

See Leukogene Therapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login